Be part of the knowledge - Prova Education

Medical News

rheumatologyadvisor.com
10/05/2022
Medical News
Focus on Cardiometabolic Disease Risk in Psoriatic Arthritis
Read more
health.harvard.edu
10/05/2022
Medical News
Treatments for Rheumatoid Arthritis May Lower Dementia Risk
Read more
physiciansweekly.com
10/05/2022
Medical News
Characterizing Inpatient Mortality in Pediatric HF
Read more

Popular

- Robert L. Coleman, MD, FACOG, FACS
  Peer
- Kathleen Moore, MD, MS
  Peer
0
CME/CE
5 Things You Need to Know in Cervical Cancer: New and Emerging Agents
5 Things You Need to Know in Cervical Cancer: New and Emerging Agents
0.25 credits
5 Things You Need to Know in Cervical Cancer: New and Emerging Agents
0.25 credits
- Donna Ryan, MD
  Peer
- Juan Pablo Frías, MD
  Peer
4
CME/CE
Beyond A1c: Practical Strategies for Managing Obesity in Patients with T2D
Beyond A1c: Practical Strategies for Managing Obesity in Patients with T2D
0.25 credits
Beyond A1c: Practical Strategies for Managing Obesity in Patients with T2D
0.25 credits
- Christina Y. Weng, MD, MBA
  Peer
- Margaret A. Chang, MD, MS
  Peer
0
CME/CE
The Future Is Now: What We’ve Learned About Implantable Anti-VEGF Technology
The Future Is Now: What We’ve Learned About Implantable Anti-VEGF Technology
0.25 credits
The Future Is Now: What We’ve Learned About Implantable Anti-VEGF Technology
0.25 credits
- David Eichenbaum, MD
  Peer
- Mark R. Barakat, MD
  Peer
2
CME/CE
Retina Clinic: Current Treatment Options in DME
Retina Clinic: Current Treatment Options in DME
0.25 credits
Retina Clinic: Current Treatment Options in DME
0.25 credits
- Carl Danzig, MD
  Peer
- Arshad M. Khanani, MD, MA
  Peer
0
CME/CE
Retina Clinic: Current Treatment Options in nAMD
Retina Clinic: Current Treatment Options in nAMD
0.25 credits
Retina Clinic: Current Treatment Options in nAMD
0.25 credits
- Shaji K. Kumar, MD
  Peer
- María-Victoria Mateos, MD, PhD
  Peer
0
CME/CE
Multiple Myeloma: Updates from ASCO 2022
Multiple Myeloma: Updates from ASCO 2022
0.25 credits
Multiple Myeloma: Updates from ASCO 2022
0.25 credits

CME/CE

- Guillermo Garcia-Manero, MD
  Peer
- Rami Komrokji, MD
  Peer
0
CME/CE
A Primer on the Management of MDS-Associated Anemia
A Primer on the Management of MDS-Associated Anemia
0.25 credits
A Primer on the Management of MDS-Associated Anemia
0.25 credits
- John Kitchens, MD
  Peer
- SriniVas R. Sadda, MD
  Peer
0
CME/CE
The Future Is Now: A Closer Look at Implantable Anti-VEGF Technology
The Future Is Now: A Closer Look at Implantable Anti-VEGF Technology
0.25 credits
The Future Is Now: A Closer Look at Implantable Anti-VEGF Technology
0.25 credits
- Mark Socinski, MD
  Peer
- Jennifer Marie Suga, MD, MPH
  Peer
2
CME/CE
Personalizing NSCLC: The Optimal Applicability of NGS and Liquid Biopsy
Personalizing NSCLC: The Optimal Applicability of NGS and Liquid Biopsy
0.25 credits
Personalizing NSCLC: The Optimal Applicability of NGS and Liquid Biopsy
0.25 credits
- Susan O’Brien, MD
  Peer
- Timothy Call, MD
  Peer
1
CME/CE
State of the Union: A Targeted Approach in First-Line Treatment of CLL/SLL
State of the Union: A Targeted Approach in First-Line Treatment of CLL/SLL
0.25 credits
State of the Union: A Targeted Approach in First-Line Treatment of CLL/SLL
0.25 credits
- Ian W. Flinn, MD, PhD
  Peer
- William Wierda, MD
  Peer
1
CME/CE
Tackling Adverse Events Associated with Disruption of B-Cell Receptor Signaling: A Multispecialty Approach
Tackling Adverse Events Associated with Disruption of B-Cell Receptor Signaling: A Multispecialty Approach
0.25 credits
Tackling Adverse Events Associated with Disruption of B-Cell Receptor Signaling…
0.25 credits
- Cesar Rodriquez Valdes, MD
  Peer
- Amrita Krishnan, MD
  Peer
4
CME/CE
Keeping Pace in Hematologic Malignancies: Novel Targets for Multiple Myeloma
Keeping Pace in Hematologic Malignancies: Novel Targets for Multiple Myeloma
0.25 credits
Keeping Pace in Hematologic Malignancies: Novel Targets for Multiple Myeloma
0.25 credits

Clinical Practice

- Cem Akin, MD, PhD
  Peer
- Jason Gotlib, MD, MS
  Peer
3
CME/CE
Indolent Systemic Mastocytosis (ISM): Tools to Diagnose ISM
Indolent Systemic Mastocytosis (ISM): Tools to Diagnose ISM
0.25 credits
Indolent Systemic Mastocytosis (ISM): Tools to Diagnose ISM
0.25 credits
- Monique Hartley-Brown, MD, MMSc
  Peer
- Shonali Midha, MD
  Peer
3
CME/CE
Keeping Pace in Hematologic Malignancies: Newly Diagnosed Multiple Myeloma
Keeping Pace in Hematologic Malignancies: Newly Diagnosed Multiple Myeloma
0.25 credits
Keeping Pace in Hematologic Malignancies: Newly Diagnosed Multiple Myeloma
0.25 credits
- Shaji K. Kumar, MD
  Peer
- María-Victoria Mateos, MD, PhD
  Peer
3
CME/CE
Keeping Pace in Hematologic Malignancies: Updates from ASCO 2022
Keeping Pace in Hematologic Malignancies: Updates from ASCO 2022
0.25 credits
Keeping Pace in Hematologic Malignancies: Updates from ASCO 2022
0.25 credits
- Rajendra Apte, MD, PhD
  Peer
- Jennifer I. Lim, MD, FARVO
  Peer
- Adrienne W. Scott, MD
  Peer
0
CME/CE
New Treatment Strategies for Diabetic Retinopathy: Sharpening the Focus
New Treatment Strategies for Diabetic Retinopathy: Sharpening the Focus
0.25 credits
New Treatment Strategies for Diabetic Retinopathy: Sharpening the Focus
0.25 credits
- Carolyn E. Majcher, OD, FAAO
  Peer
- Diana Shechtman, OD, FAAO
  Peer
2
CME/CE
New Strategies for Managing Diabetic Retinopathy
New Strategies for Managing Diabetic Retinopathy
0.25 credits
New Strategies for Managing Diabetic Retinopathy
0.25 credits
- Avni P. Finn, MD, MBA
  Peer
- Jayanth Sridhar, MD
  Peer
2
CME/CE
New Perspectives on Managing Diabetic Retinopathy
New Perspectives on Managing Diabetic Retinopathy
0.25 credits
New Perspectives on Managing Diabetic Retinopathy
0.25 credits

Programs

- Kara Markhakb, MD
  Peer
- Bethany Weathersby, MS
  Peer
- James B. Bussel, MD
  Peer
2
CME/CE Meeting
CME/CE Meeting
Hemolytic Disease of the Fetus and Newb…
Anaheim, CA 92802
October 10, 2022
06:30 PM - 08:30 PM PDT
1.50 creditsLearn more
- Amrita Krishnan, MD
  Peer
- Morie Gertz, MD, MACP
  Peer
3
CME/CE
Keeping Pace in Hematologic Malignancies: Optimizing Treatment Selection in Relapsed or Refractory Multiple Myeloma
Keeping Pace in Hematologic Malignancies: Optimizing Treatment Selection in Relapsed or Refractory Multiple Myeloma
0.25 credits
Keeping Pace in Hematologic Malignancies: Optimizing Treatment Selection in Rel…
0.25 credits
- Susan B. Bressler, MD
  Peer
- Mark Dunbar, OD, FAAO
  Peer
- Ruth S. Weinstock, MD, PhD
  Peer
1
CME/CE
Saving Sight in Your Patients with Diabetes: What You Might Be Missing
Saving Sight in Your Patients with Diabetes: What You Might Be Missing
0.25 credits
Saving Sight in Your Patients with Diabetes: What You Might Be Missing
0.25 credits
- Richard Elion, MD
  Peer
4
CME/CE
Best Practices for Taking a Sexual History: Destigmatizing PrEP Care
Best Practices for Taking a Sexual History: Destigmatizing PrEP Care
0.25 credits
Best Practices for Taking a Sexual History: Destigmatizing PrEP Care
0.25 credits
- Lyudmila Bazhenova, MD
  Peer
- Benjamin Levy, MD
  Peer
7
CME/CE
The Emerging Role of HER2 (ERBB2) Mutations in NSCLC
The Emerging Role of HER2 (ERBB2) Mutations in NSCLC
0.25 credits
The Emerging Role of HER2 (ERBB2) Mutations in NSCLC
0.25 credits
- Amer Zeidan, MBBS
  Peer
- Amy E. DeZern, MD, MHS
  Peer
5
CME/CE
Managing and Monitoring MDS: MDS-Related Effects and Progression to AML
Managing and Monitoring MDS: MDS-Related Effects and Progression to AML
0.25 credits
Managing and Monitoring MDS: MDS-Related Effects and Progression to AML
0.25 credits